Haloperidol decanoate and Atrial fibrillation/flutter - a phase IV clinical study of FDA data
Summary:
Atrial fibrillation/flutter is reported as a side effect among people who take Haloperidol decanoate (haloperidol decanoate), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Depakote, and have Schizophrenia.
The phase IV clinical study analyzes which people have Atrial fibrillation/flutter when taking Haloperidol decanoate. It is created by eHealthMe based on reports of 1,886 people who have side effects when taking Haloperidol decanoate from the FDA, and is updated regularly.
What is Haloperidol decanoate?
Haloperidol decanoate has active ingredients of haloperidol decanoate. eHealthMe is studying from 1,890 Haloperidol decanoate users. Check the latest studies of Haloperidol decanoate.
What is Atrial fibrillation/flutter?
Atrial fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles) is found to be associated with 2,362 drugs and 3,844 conditions by eHealthMe. Check the latest studies of Atrial fibrillation/flutter.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
1,886 people reported to have side effects when taking Haloperidol decanoate.
Among them, 18 people (0.95%) have Atrial fibrillation/flutter.

Among these 18 people:
How long have people been on Haloperidol decanoate when they have Atrial fibrillation/flutter? *
- < 1 month: 100 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Atrial fibrillation/flutter when taking Haloperidol decanoate? *
- female: 11.76 %
- male: 88.24 %
What is the age of people who have Atrial fibrillation/flutter when taking Haloperidol decanoate? *
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 31.25 %
- 50-59: 0.0 %
- 60+: 68.75 %
What are other drugs people take besides Haloperidol decanoate? *
- Depakote: 7 people, 38.89%
- Lorazepam: 5 people, 27.78%
- Vancomycin: 5 people, 27.78%
- Subutex: 5 people, 27.78%
- Oxazepam: 4 people, 22.22%
- Lisinopril: 1 person, 5.56%
- Angiomax: 1 person, 5.56%
- Aspirin: 1 person, 5.56%
- Ativan: 1 person, 5.56%
- Benadryl: 1 person, 5.56%
What are other side effects people have besides Atrial fibrillation/flutter? *
- Pneumonia: 8 people, 44.44%
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 7 people, 38.89%
- Sepsis (a severe blood infection that can lead to organ failure and death): 7 people, 38.89%
- Bacterial Infection: 7 people, 38.89%
- Pleural Effusion (water on the lungs): 7 people, 38.89%
- Klebsiella Infection: 7 people, 38.89%
- Phlebitis Superficial (inflammation of the walls of a vein-superficial): 6 people, 33.33%
- Unresponsive To Stimuli: 6 people, 33.33%
- Basedow's Disease (autoimmune disease where the thyroid is overactive, producing an excessive amount of thyroid hormones): 5 people, 27.78%
- Ventricular Fibrillation (abnormally irregular heart rhythm): 1 person, 5.56%
What are the existing conditions these people have? *
- Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 7 people, 38.89%
- Pneumonia Aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree): 5 people, 27.78%
- Phlebitis Superficial (inflammation of the walls of a vein-superficial): 5 people, 27.78%
- Legionella Infection (a lung infection caused by bacteria of the species legionella): 5 people, 27.78%
- Insomnia (sleeplessness): 5 people, 27.78%
- Delusion (a false belief or opinion): 5 people, 27.78%
- Agitation (state of anxiety or nervous excitement): 2 people, 11.11%
- Oral Pain: 1 person, 5.56%
- Lung Cancer - Non-Small Cell (lung cancer): 1 person, 5.56%
- Klebsiella Infection: 1 person, 5.56%
* Approximation only. Some reports may have incomplete information.
Do you take Haloperidol decanoate and have Atrial fibrillation/flutter?
- Check whether Atrial fibrillation/flutter is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Haloperidol decanoate:
- Haloperidol decanoate (1,890 reports)
Atrial fibrillation/flutter treatments and more:
- Atrial fibrillation/flutter (349,232 reports)
How severe was Atrial fibrillation/flutter and when was it recovered:
Expand to all the drugs that have ingredients of haloperidol decanoate:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Haloperidol decanoate:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Atrial fibrillation/flutter:
- Atrial fibrillation/flutter (2,362 drugs)
Browse all the conditions that are associated with Atrial fibrillation/flutter:
- Atrial fibrillation/flutter (3,844 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on haloperidol decanoate (the active ingredients of Haloperidol decanoate) and Haloperidol decanoate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Flomax cause Subcutaneous Nodule? - 3 seconds ago
- Could Tenormin cause Injection Site Erythema? - 7 seconds ago
- Could Prolia cause Aphthous Stomatitis? - 13 seconds ago
- Could Zoloft cause Vaginitis? - 16 seconds ago
- Could Prevacid cause Adverse Reaction? - 16 seconds ago
- Could Transderm Scop cause Dyspnea Exacerbated? - 21 seconds ago
- Could Plaquenil cause Liver Disorder? - 23 seconds ago
- Could Onglyza cause Haemoglobin Decreased? - 29 seconds ago
- How effective is Nyquil for Cough? - 33 seconds ago
- Could Nystatin cause Empyema? - 34 seconds ago